271 Results

Spectrum News: Doctors explain high COVID-19 death rate despite...

May 19, 2022

With the United States recently hitting one million COVID-19 deaths, many are wondering why there have been so many deaths despite having a higher than average vaccination rate. Medical professionals explained the current climate of COVID-19 in the hospitals and area communities. One of the experts interviewed for a story posted by Spectrum News was Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine.

Medscape: Analysis boosts Fluvoxamine for COVID, but what's the...

April 14, 2022

A report published recently in JAMA Open Network finds there's a strong likelihood that the antidepressant fluvoxamine (Luvox) may moderately lower rates of hospitalization due to COVID-19 in unvaccinated patients. However, outside experts cited by Medscape differ over whether the evidence from just three studies is strong enough to warrant adding the drug to the COVID-19 armamentarium. One of those experts sources is Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine.

Cincinnati.com: The COVID-19 virus isn't gone, but rules have...

March 18, 2022

With COVID-19 cases declining, some school districts in the Cincinnati region are no longer requiring masks to be worn in class. The Ohio Department of Health announced recently that it would end daily reporting of COVID-19 cases. In a story published by Cincinnati.com, several local infectious disease experts were asked about a variety of practices as society emerges from the pandemic. One of the sources was Jennifer Forrester, MD, and another was Carl Fichtenbaum, MD, both of the Division of Infectious Diseases at the UC College of Medicine.

WVXU: 'Springing' forward means more daylight but also more...

March 14, 2022

A Congressional committee heard testimony this week on the pros and cons of switching between standard and daylight saving time. Many people say they like having the extra hour of daylight, but sleep professionals say it's a bad idea. The American Academy of Sleep Medicine is continuing the push to abolish daylight saving time. Research shows most people get an hour less sleep on daylight saving time. That has a host of health and safety implications. In a story posted by WVXU, Ann Romaker, MD, of the Division of Pulmonary, Critical Care and Sleep Medicine and director of the Sleep Medicine Center at UC Medical Center, said the time change creates the potential for a variety of health problems.

Healthline: Avian flu outbreak in the US: What to know right now

February 22, 2022

Health experts in the United States are monitoring an increase in cases of bird flu in several states, including Indiana, Kentucky and Virginia. In January, the United States Department of Agriculture detected the first U.S. bird flu case after a hunted wild bird tested positive for the virus in Colleton County, South Carolina. Experts reported that it was the H5N1 strain, a highly pathogenic avian influenza virus (HPAI) — the same strain responsible for fatal poultry outbreaks across Europe and Asia in late 2021. In a story on the increase in bird flu published by Healthline, Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was one of the experts cited.

UC research helps develop new medicines for treating heart...

February 17, 2022

New UC research discovered a unique class of medications that act as blood thinners by inhibiting an enzyme in the genes of tick saliva. The research focused on novel direct thrombin inhibitors (DTI) from tick salivary transcriptomes, or messenger RNA molecules expressed by an organism. The result is the development of new anticoagulant medications that can be used to treat patients with a variety of coronary issues, including heart attacks. The study was published in Nature Communication.

UC joins nationwide clinical study to test medications for...

February 15, 2022

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications. ACTIV-6, “The Randomized Trial to Evaluate Efficacy of Repurposed Medications,” is a nationwide double-blind study expected to enroll nearly 15,000 participants from across the United States through its website.

Load More
Debug Query for this